These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 19165203)

  • 41. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
    Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
    Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells.
    Li Y; Wang H; Oosterwijk E; Tu C; Shiverick KT; Silverman DN; Frost SC
    Cancer Invest; 2009 Jul; 27(6):613-23. PubMed ID: 19367501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
    Colpaert CG; Vermeulen PB; Fox SB; Harris AL; Dirix LY; Van Marck EA
    Breast Cancer Res Treat; 2003 Sep; 81(2):137-47. PubMed ID: 14572156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer.
    Winter SC; Shah KA; Han C; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
    Cancer; 2006 Aug; 107(4):757-66. PubMed ID: 16826581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer.
    Ilie M; Mazure NM; Hofman V; Ammadi RE; Ortholan C; Bonnetaud C; Havet K; Venissac N; Mograbi B; Mouroux J; Pouysségur J; Hofman P
    Br J Cancer; 2010 May; 102(11):1627-35. PubMed ID: 20461082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
    Generali D; Fox SB; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield SM; Bruzzi P; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Bottini A; Harris AL
    Endocr Relat Cancer; 2006 Sep; 13(3):921-30. PubMed ID: 16954440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
    Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases.
    Rajaganeshan R; Prasad R; Guillou PJ; Scott N; Poston G; Jayne DG
    Eur J Surg Oncol; 2009 Dec; 35(12):1286-94. PubMed ID: 19540709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is the hypoxia-inducible factor pathway important in gastric cancer?
    Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM
    Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.
    Chu CY; Jin YT; Zhang W; Yu J; Yang HP; Wang HY; Zhang ZJ; Liu XP; Zou Q
    Int J Oncol; 2016 Jan; 48(1):271-80. PubMed ID: 26648580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.
    Kaluz S; Kaluzová M; Chrastina A; Olive PL; Pastoreková S; Pastorek J; Lerman MI; Stanbridge EJ
    Cancer Res; 2002 Aug; 62(15):4469-77. PubMed ID: 12154057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.
    Nordsmark M; Eriksen JG; Gebski V; Alsner J; Horsman MR; Overgaard J
    Radiother Oncol; 2007 Jun; 83(3):389-97. PubMed ID: 17499868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
    Cleven AH; van Engeland M; Wouters BG; de Bruïne AP
    Cell Oncol; 2007; 29(3):229-40. PubMed ID: 17452775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between carbonic anhydrase IX (CAIX) and patient survival in breast cancer: systematic review and meta-analysis.
    Shamis SAK; Edwards J; McMillan DC
    Diagn Pathol; 2023 Apr; 18(1):46. PubMed ID: 37061698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
    Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
    Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
    Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients.
    Kaya AO; Gunel N; Benekli M; Akyurek N; Buyukberber S; Tatli H; Coskun U; Yildiz R; Yaman E; Ozturk B
    J BUON; 2012; 17(4):663-8. PubMed ID: 23335522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.
    Beketic-Oreskovic L; Ozretic P; Rabbani ZN; Jackson IL; Sarcevic B; Levanat S; Maric P; Babic I; Vujaskovic Z
    Pathol Oncol Res; 2011 Sep; 17(3):593-603. PubMed ID: 21249485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
    Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
    BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.